Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder. | Front Mol Neurosci | 2023 | 37908488 | PubTator, text mining | PubMed |
| Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma. | Sci Rep | 2023 | 37903971 | PubTator, text mining | PubMed |
| Targeting Lactate Dehydrogenase-B as a Strategy to Fight Cancer: Identification of Potential Inhibitors by In Silico Analysis and In Vitro Screening. | Pharmaceutics | 2023 | 37896171 | PubTator, text mining | PubMed |
| The Significance of Microenvironmental and Circulating Lactate in Breast Cancer. | Int J Mol Sci | 2023 | 37895048 | PubTator, text mining | PubMed |
| CD44 Intracellular Domain: A Long Tale of a Short Tail. | Cancers (Basel) | 2023 | 37894408 | PubTator, text mining | PubMed |
| Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis. | Cancers (Basel) | 2023 | 37894282 | PubTator, text mining | PubMed |
| LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression. | Res Sq | 2023 | 37886538 | PubTator, text mining | PubMed |
| DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia. | Technol Cancer Res Treat | 2023 | 37872685 | PubTator, text mining | PubMed |
| Lactate dehydrogenase D is a general dehydrogenase for D-2-hydroxyacids and is associated with D-lactic acidosis. | Nat Commun | 2023 | 37863926 | PubTator, text mining | PubMed |
| Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane: a case report. | J Med Case Rep | 2023 | 37858266 | PubTator, text mining | PubMed |
| ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner. | J Transl Med | 2023 | 37858219 | PubTator, text mining | PubMed |
| Preparation of a Mesoporous Biosensor for Human Lactate Dehydrogenase for Potential Anticancer Inhibitor Screening. | ACS Biomater Sci Eng | 2023 | 37856794 | PubTator, text mining | PubMed |
| The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer. | J Transl Med | 2023 | 37853445 | PubTator, text mining | PubMed |
| Warburg-associated acidification represses lactic fermentation independently of lactate, contribution from real-time NMR on cell-free systems. | Sci Rep | 2023 | 37853114 | PubTator, text mining | PubMed |
| Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa. | Int J Mol Sci | 2023 | 37834386 | PubTator, text mining | PubMed |
| Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction. | Nat Commun | 2023 | 37833292 | PubTator, text mining | PubMed |
| Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets. | Cells | 2023 | 37830606 | PubTator, text mining | PubMed |
| Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling. | Cell Biosci | 2023 | 37828561 | PubTator, text mining | PubMed |
| Progenitor-like cell type of an MLL-EDC4 fusion in acute myeloid leukemia. | Blood Adv | 2023 | 37820244 | PubTator, text mining | PubMed |
| Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect. | Cell Death Dis | 2023 | 37816733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=15